Microdosing GLP-1 means using doses significantly below the approved therapeutic range, but this practice lacks clinical trial evidence and is not approved by the MHRA
Eckschlager, T
Due to their high surface area, charge density, and unique reactivity, nanomaterials can provoke cellular oxidative stress, mitochondrial dysfunction, lysosomal impairment, and activation of pro-inflammatory pathways [475,476,477,478]
Laboratory animal studies report that ipamorelin can cause an increase in appetite and weight gain, which may include fat gain [20]
Our weight loss program in Waco, Texas uses GLP-1 medications including Ozempic, Mounjaro, Wegovy, Zepbound and more to help patients lose weight